Blood Cancer Drugs Market: Competitive Landscape and Pharmaceutical Developments
Estimated at USD 67.50 billion in 2025, the Blood Cancer Drugs Market is projected to grow from USD 74.44 billion in 2026 to USD 164.04 billion by 2034, registering a CAGR of 10.4% during 2026–2034. North America dominated in 2025. Rising incidence of hematological malignancies and longer treatment durations drive demand. Leukemia targeted therapies held the largest indication share...
0 التعليقات 0 المشاركات 94 مشاهدة 0 معاينة
SocioMint https://sociomint.com